Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Stewart

Showing results (111-120 of 127) with videos related to

Pageof 13
Sort By:
Journal for Immunotherapy of Cancer|September 22, 2025
Molecular response cutoffs and ctDNA collection timepoints influence on interpretation of associations between early changes in ctDNA and overall survival in patients treated with anti-PD(L)1 and/or chemotherapyHillary S Andrews, Nevine Zariffa, Katherine K Nishimura, et al.
Influenza and Other Respiratory Viruses|May 3, 2021
A remote household-based approach to influenza self-testing and antiviral treatmentJessica Heimonen, Denise J McCulloch, Jessica O'Hanlon, et al.
Journal for Immunotherapy of Cancer|April 13, 2026
Data-informed optimization of CAR T-cell therapy long-term follow-upBetsy Foss-Campbell, Nancy Myers, Rakesh Awasthi, et al.
Clinical and Translational Science|March 12, 2025
Establishing a Common Lexicon for Circulating Tumor DNA Analysis and Molecular Residual Disease: Insights From the BLOODPAC ConsortiumAndrew G Hadd, Angela Silvestro, Brittany Avin McKelvey, et al.
Clinical Pharmacology and Therapeutics|November 21, 2022
The Aetion Coalition to Advance Real-World Evidence through Randomized Controlled Trial Emulation Initiative: OncologyDavid Merola, Ulka Campbell, Nileesa Gautam, et al.
JCO Oncology Practice|August 29, 2023
Sponsor Perspectives on the Impact of the COVID-19 Pandemic on Interventional Cancer Clinical Trial Protocols and Data QualityJoseph M Unger, Hillary Stires, Laura A Levit, et al.
Journal of Medical Internet Research|December 11, 2025
Digital Biomarkers of Cytokine Release Syndrome: Scoping Review and Ontology Development of the Role and Relevance of Digital Measures Using a Mixed Methods ApproachChristopher J Medberry, Charlotte Zoe Angel, Ashita S Batavia, et al.
Clinical and Translational Science|August 29, 2024
Lexicon for blood-based early detection and screening: BLOODPAC consensus documentChristina A Clarke, Breeana L Mitchell, Girish Putcha, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 3, 2020
Harmonization and Standardization of Panel-Based Tumor Mutational Burden Measurement: Real-World Results and Recommendations of the Quality in Pathology StudyAlbrecht Stenzinger, Volker Endris, Jan Budczies, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 27, 2019
Spatial and Temporal Heterogeneity of Panel-Based Tumor Mutational Burden in Pulmonary Adenocarcinoma: Separating Biology From Technical ArtifactsDaniel Kazdal, Volker Endris, Michael Allgäuer, et al.
Pageof 13

Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
Journal for Immunotherapy of Cancer|September 22, 2025
Molecular response cutoffs and ctDNA collection timepoints influence on interpretation of associations between early changes in ctDNA and overall survival in patients treated with anti-PD(L)1 and/or chemotherapyHillary S Andrews, Nevine Zariffa, Katherine K Nishimura, et al.
Influenza and Other Respiratory Viruses|May 3, 2021
A remote household-based approach to influenza self-testing and antiviral treatmentJessica Heimonen, Denise J McCulloch, Jessica O'Hanlon, et al.
Journal for Immunotherapy of Cancer|April 13, 2026
Data-informed optimization of CAR T-cell therapy long-term follow-upBetsy Foss-Campbell, Nancy Myers, Rakesh Awasthi, et al.
Clinical and Translational Science|March 12, 2025
Establishing a Common Lexicon for Circulating Tumor DNA Analysis and Molecular Residual Disease: Insights From the BLOODPAC ConsortiumAndrew G Hadd, Angela Silvestro, Brittany Avin McKelvey, et al.
Clinical Pharmacology and Therapeutics|November 21, 2022
The Aetion Coalition to Advance Real-World Evidence through Randomized Controlled Trial Emulation Initiative: OncologyDavid Merola, Ulka Campbell, Nileesa Gautam, et al.
JCO Oncology Practice|August 29, 2023
Sponsor Perspectives on the Impact of the COVID-19 Pandemic on Interventional Cancer Clinical Trial Protocols and Data QualityJoseph M Unger, Hillary Stires, Laura A Levit, et al.
Journal of Medical Internet Research|December 11, 2025
Digital Biomarkers of Cytokine Release Syndrome: Scoping Review and Ontology Development of the Role and Relevance of Digital Measures Using a Mixed Methods ApproachChristopher J Medberry, Charlotte Zoe Angel, Ashita S Batavia, et al.
Clinical and Translational Science|August 29, 2024
Lexicon for blood-based early detection and screening: BLOODPAC consensus documentChristina A Clarke, Breeana L Mitchell, Girish Putcha, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 3, 2020
Harmonization and Standardization of Panel-Based Tumor Mutational Burden Measurement: Real-World Results and Recommendations of the Quality in Pathology StudyAlbrecht Stenzinger, Volker Endris, Jan Budczies, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 27, 2019
Spatial and Temporal Heterogeneity of Panel-Based Tumor Mutational Burden in Pulmonary Adenocarcinoma: Separating Biology From Technical ArtifactsDaniel Kazdal, Volker Endris, Michael Allgäuer, et al.
Pageof 13